CAS |
No.514-65-8 |
中文名称 |
比哌立登 |
英文名称 |
Biperiden |
别名 |
碧卜利旦;KL 373 |
分子式 |
C21H29NO |
分子量 |
311.46 |
溶解性 |
Soluble in DMSO |
纯度 |
≥98% |
外观(性状) |
Solid |
储存条件 |
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
运输条件 |
冷藏运输 |
EC |
EINECS 208-184-6 |
MDL |
MFCD05662335 |
SMILES |
C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O |
InChIKey |
YSXKPIUOCJLQIE-UHFFFAOYSA-N |
InChI |
InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2 |
PubChem CID |
2381 |
靶点 |
mAChR |
通路 |
Neuronal Signaling;GPCR & G Protein |
背景说明 |
是一种非选择性毒蕈碱受体 (muscarinic receptor) 拮抗剂,可以与 M1 毒蕈碱受体竞争性结合,从而抑制乙酰胆碱 (acetylcholine) 并增强中枢神经系统中多巴胺信号传导。 |
生物活性 |
Biperiden 是一种非选择性毒蕈碱受体拮抗剂,可竞争性地与 M1 毒蕈碱受体结合,抑制乙酰胆碱并增强中枢神经系统中的多巴胺信号传导,具有研究帕金森病等精神疾病的潜力。[1-2] |
In Vivo |
Biperiden reduced proliferation and increased apoptosis in PDAC cells in vitro and in vivo.[1] Biperiden was capable of elevating the threshold of hippocampal excitability,thereby making the hippocampal glutamatergic pathways less responsive to stimuli when high concentrations of potassium were used in vivo or in vitro.[2] Biperiden(5mg,i.p.)depress oesophageal motility,and modifies the oesophageal evoked potentials.[3] |
数据来源文献 |
[1]. Konczalla L,et al. Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer. Int J Cancer. 2020 Mar 15;146(6):1618-1630. [2]. Bittencourt S,et al. Modification of the natural progression of epileptogenesis by means of biperiden in the pilocarpine model of epilepsy. Epilepsy Res. 2017 Dec;138:88-97. [3]. Pehl C,et al. Effects of two anticholinergic drugs,trospium chloride and biperiden,on motility and evoked potentials of the oesophagus. Aliment Pharmacol Ther. 1998 Oct;12(10):979-84. |
规格 |
5mg 10mg 25mg 50mg |
单位 |
瓶 |